Background: Although the prevalence of metabolic syndrome has been studied in nationally representative populations, little is known about its prevalence specifi cally among working adults. Because corporations are often the primary payers of health-care costs in the United States, they have a vested interest in knowing the impact of metabolic syndrome in employed individuals. Methods: A total of 4188 employees (83.4% male, 92.1% Caucasian, average age 40.8 years) of a midwestern U.S. manufacturing corporation participated in a health risk appraisal and biometric screening in 2006 and also used the company's medical plan. Those with metabolic syndrome were compared to those without metabolic syndrome in terms of their 2006 health risks, health conditions, health-care costs, pharmacy costs, short-term disability costs, and a measure of on-the-job productivity loss known as presenteeism. Results: A total of 30.2% of employees met the criteria for metabolic syndrome and were more likely to also have a variety of additional health risks and health conditions compared to those without metabolic syndrome. For example, 9.4% of those with metabolic syndrome self-reported having diabetes compared to 1.4% of those without metabolic syndrome. Health-care costs, pharmacy costs, and short-term disability costs were signifi cantly higher for those with metabolic syndrome compared to those without metabolic syndrome, and increasing numbers of metabolic syndrome health risks were associated with greater numbers of employees reporting on-the-job productivity losses (presenteeism). Conclusions: Because metabolic syndrome is prevalent among the employees of this manufacturing company and is associated with signifi cant economic costs, employers would be wise to address the health risks of employees through health promotion programs and benefi t plan designs that help individuals improve their health and receive appropriate health screenings and medical care.
Introduction
S everal definitions of metabolic syndrome have been published, making it diffi cult to compare prevalence rates estimated by different studies. This cluster of metabolic risk factors was fi rst called "syndrome X" in 1988. 1 Ten years later the World Health Organization (WHO) 2 proposed its defi nition. The National Cholesterol Education Program (NCEP) developed its own defi nition in 2001 known as Adult Treatment Panel III (ATP III) 3 and in 2005, the International Diabetes Federation (IDF) introduced yet another defi nition. 4 Finally, the American Heart Association and National Heart, Lung and Blood Institute have recently confi rmed the value of the ATP III defi nition with some minor modifi cations, including the addition of a medication component. Therefore, the current worldwide standard for metabolic syndrome is three or more of the following criteria: waist circumference (≥102 cm in men, ≥88 cm in women, or body mass index (BMI) >30 kg/m 2 ), triglycerides ≥150 mg/dL or taking medication for triglycerides, high-density lipoprotein cholesterol (HDL-C) <40 mg/dL for men or <50 mg/dL for women or taking medication for HDL, blood pressure ≥130/85 mmHg or taking medication for blood pressure, and fasting glucose ≥100 mg/dL or taking medication for glucose. 5 Some research has compared the prevalence of metabolic syndrome with these different criteria. One study compared the prevalence of metabolic syndrome using the WHO 2 and ATP III 3 defi nitions among 8608 subjects. 6 About 86% of people were classifi ed the same by both defi nitions.
Health risks
The HRA was based on Healthier People, Version 4.0 (The Carter Center of Emory University, Atlanta, GA, 1991), and enhanced over time on the basis of the most recent morbidity and mortality studies in cooperation with the University of Michigan's Health Management Research Center (Ann Arbor, MI). Each participant completing the HRA received an individualized report summarizing their health risks and suggestions for health improvement. The health risks and their cut points can be found in Table 1 .
The HRA also included data from a biometric screening that used venipuncture for blood glucose and lipid panel variables and measured height and weight. A third-party laboratory was contracted for the venipuncture procedure. The screening results provided the information on metabolic syndrome risk factors. In this study, the risks currently accepted as the best indicators of metabolic syndrome were used. 5 Therefore, in this employed population, the following risks were used: blood pressure ≥130/85 mmHg, fasting glucose ≥100 mg/dL, triglycerides ≥150 mg/dL, and HDL-C <40 mg/dL in men and <50 mg/dL in women. Waist circumference was not measured at this company's screening until 2007, so a BMI >30 kg/m 2 was used as a surrogate. As indicated in the current criteria of metabolic syndrome, if individuals have a BMI greater than 30 kg/m 2 , it can safely be assumed that their waist circumference exceeds the risk level. 17 Individuals with at least three of the risks were considered to have metabolic syndrome.
In addition to asking employees about the presence of 16 biological and lifestyle health-risk factors, the HRA included the following question about the presence of several chronic diseases: Do you currently have any of the following? The list included: seasonal allergies, asthma, arthritis, back pain, cancer (any type), chronic bronchitis/emphysema, depression, diabetes mellitus, heartburn, heart disease, high cholesterol, hypertension, irritable bowel syndrome, kidney disease, migraine, osteoporosis, and stroke. Additionally, respondents were asked whether they were either being treated by a physician or currently taking medications for Although the overall estimates were very similar (23.9% and 25.1% prevalence rates), signifi cant differences were noted among certain population subgroups. For example, among African-American men, 16.5% had metabolic syndrome using the ATP III criteria whereas 24.9% met the defi nition of the WHO. The ATP III defi nition of metabolic syndrome is more focused on its relationship to cardiovascular disease, which may account for some of the difference with the WHO defi nition. 2 A German study compared the WHO, ATP III, and IDF defi nitions of metabolic syndrome to identify the difference in prevalence rates among individuals who already had type 2 diabetes. 7 The degree of agreement was much stronger between the ATP III and IDF defi nitions (κ = 0.69) compared to the WHO versus IDF (κ = 0.12) and WHO versus ATP III (κ = 0.17). An epidemiological study in India also compared the WHO, ATP III, and IDF defi nitions and found the three defi nitions identifi ed different individuals. While 841 of the 2350 subjects were positively identifi ed as having metabolic syndrome by at least one of the defi nitions, only 224 were identifi ed by all three defi nitions. 8 Other studies using the ATP III defi nition of metabolic syndrome among nationally representative datasets have found prevalence rates in the United States ranging from 22.7% 9 to 23.7%. 10 In both of those studies, prevalence rates varied widely in ethnic subgroups.
Few studies have determined the prevalence of metabolic syndrome risks in working populations. One such study in a worksite found a prevalence rate of 27%, 11 which is in line with population-based studies. Another study of a working population in 2001 identifi ed groups of risks measured by a Health Risk Appraisal (HRA) questionnaire using cluster analysis. One of the four identifi ed clusters was termed the "biometric cluster." 12 It was apparent to those researchers that a cluster of health risks, including blood pressure, cholesterol, and overweight, often traveled together, as did other clusters of risks such as a psychological cluster (life satisfaction, stress, perceived health) and a risk-taking cluster (alcohol use, safety belt use, smoking).
Many studies have found a strong association between metabolic syndrome risks with both heart disease and diabetes. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] But again, none of these studies was conducted specifi cally in a working population. Considering that employees at this corporation have access to low-cost health care as well as a relatively large income compared to many subjects in nationally representative samples, it is hypothesized that the prevalence of metabolic syndrome will be lower in this population. As corporations are the main payers of healthcare costs in the United States, they have a vested interest in identifying the magnitude of metabolic syndrome risks in employed populations and also in knowing if those risks are associated with other health risks or medical conditions or economic outcomes such as health-care costs or productivity. Many companies offer wellness programs to encourage employees to maintain their health and reduce health risks, such as those that comprise metabolic syndrome.
The aim of this study was to identify the prevalence of metabolic syndrome risks in employees of a large manufacturing corporation. Furthermore, the association between metabolic syndrome and other health risks and conditions was also determined in this employed population. The economic costs (health-care costs, pharmaceutical costs, shortterm disability absenteeism, and on-the-job productivity STD cost. They were also signifi cantly older (42.9 years vs. 40.4 years, P < 0.05). At this company, STD pays a weekly benefi t for full-time, hourly employees and is paid at 100%. The maximum duration of STD benefi ts paid is 26 weeks. If the employee is still disabled after 26 weeks, they are eligible for another 26 weeks on STD, but will not be paid. Long-term disability coverage is not offered to the majority of employees, so the cost of that benefi t is not included here. As with medical and pharmacy claims, the STD data were merged with the employee health and personnel information.
Presenteeism
On-the-job productivity was measured by a subset of the Work Limitations Questionnaire (WLQ) included in the HRA to assess the health-related impact on work productivity. Eight questions (two from each WLQ work domain) were selected from the original 25 WLQ questions and the eightitem subset of questions have been used in previous studies. [23] [24] [25] [26] These questions evaluated the percentage of time at work that a physical or emotional problem interfered with any of the following work areas: time management (working the required number of hours, starting work on time); physical work (repeating the same hand motions, using work equipment); mental/interpersonal activities (concentration, teamwork); and output demand (completing the require amount of work, working to your capability). More detail on the eight-item WLQ questionnaire can be found in a previous study 27 and the eight items can be found in Table 2 . Employees were asked to base their answers on the conditions that they had reported. If an individual reported either currently having a given condition, or being under medical care or taking medication, they were considered to have that particular condition. If employees reported taking medication for diabetes, high blood pressure, or high cholesterol, those criteria were considered in the metabolic syndrome risk determination as well.
Medical and pharmacy claims
Medical and pharmacy claims were also available for the population studied and were provided by a third-party administrator. The medical insurance provider and pharmacy benefi t manager for this company provided each claim incurred by each employee in 2006 via encrypted transmission. Medical claims from 2006 were summed to create a total for each individual as were pharmacy claims. These claims data were then merged with employee health-risk and personnel data.
Short-term disability absences
Short-term disability (STD) absences were used as a measure of productivity loss. STD absences in 2006 were summed for each individual, as was their STD cost, which was provided by the company. A total of 232 individuals (5.5% of the study population) incurred a nonpregnancy STD cost during the study time period. Those with nonpregnancy STD costs were signifi cantly more likely to be female (25.9% vs. 16.2%, P < 0.0001) compared to those without an (n = 2922, 69.8%) had less than three of the risk factors while 1266 individuals (30.2%) were considered to have metabolic syndrome because they had three or more of the risks.
The demographics of individuals with and without metabolic syndrome were then analyzed, and the results are shown in Table 4 . Those with metabolic syndrome (n = 1266) were nearly 4 years older than those without the syndrome (43.1 vs. 39.6 years, P < 0.0001). A signifi cantly greater percentage of those with metabolic syndrome were male compared to those without metabolic syndrome (89.6% vs. 80.7%, P < 0.0001). Because of these signifi cant differences, and also because other researchers have identifi ed that age and gender are signifi cant confounding variables, 8, 9 all further analyses controlled for age and gender. A greater percentage of those with metabolic syndrome had education less than a previous 2 weeks of work and to rate any impairment on a 5-point scale with options of "none of the time (0%)," "some of the time," "half of the time (50%)," "most of the time," and "all of the time (100%)." Additionally, employees were able to select a response of "does not apply to my job," which was treated as a missing answer for that item. The response for each domain was judged to be valid if at least one of the two items was nonmissing. A dichotomous score (yes/no) indicated whether or not any work limitations were noted for any domain (ie, amount of limitation >0%).
Statistical analyses
Differences in continuous and categorical variables in individuals with and without metabolic syndrome were tested using t-tests and chi-squared analyses, respectively. Logistic and generalized linear models were used to identify factors associated with the presence of metabolic syndrome while controlling for demographic variables. The Cochran-Armitage test for trend was used to analyze whether or not the percentage of employees reporting any presenteeism was higher as the number of metabolic syndrome risks increased. All analyses were conducted using SAS 9.1 software. (SAS Institute Inc., Cary, NC). This study was approved by the University of Michigan's Institutional Review Board.
Results
First the prevalence of the fi ve metabolic syndrome health risks in this employed population was explored. Table 3 shows the percentage of employees with each of the fi ve metabolic syndrome risk factors as well as by number of metabolic syndrome risks.
In this group of people employed in a manufacturing company, 36.6% had high blood pressure or reported the use of blood pressure medication, 32.0% had a BMI >30, 32.0% had a fasting glucose level greater than or equal to 100 or reported using diabetes medication, 33.1% had low HDL-C or reported taking cholesterol medication, and 42.2% met the criteria for high triglycerides. In all, only 23.1% (n = 968) of the population had none of the fi ve risks, while 3.4% (n = 144) had all fi ve risks. Almost 70% of the population risks are selected from 10 variables that demonstrate strong associations with future medical claims costs as determined by multiple research studies. These variables include smoking status, physical activity, alcohol consumption, safety belt usage, blood pressure, total cholesterol, HDL-C, body weight, illness days, and self-assessment of health. The mortality risks are calculated as a function of the rates between achievable and appraised probabilities of the deaths from all causes in the next 10 years according to a HRA participant's age, gender, and health risks. The preventive services selected are based on the fi ndings and recommendations of the U.S. Preventive Services Task Force Guidelines 28 according to participants' age and gender.
Additional self-reported medical conditions were then compared for those with and without metabolic syndrome and results are found in Table 5 . Those with metabolic syndrome were signifi cantly more likely to report having arthritis, chronic bronchitis/emphysema, chronic pain, depression, diabetes, heart problems, heartburn/acid refl ux, and stroke compared to employees without metabolic syndrome, after college degree (79.2% vs. 73.3%, P = 0.0462 after controlling for age and gender). Hourly employee status, marital status, and ethnicity were not signifi cantly different after controlling for age and gender.
The additional health risks measured by the HRA were also compared for those with and without metabolic syndrome. Those with metabolic syndrome were signifi cantly more likely also to be at risk for high total cholesterol, illness days, the use of relaxation medication, perceived physical health, physical inactivity, safety belt use, and high stress after controlling for age and gender. When the overall wellness score calculated for each HRA participant was compared, employees with metabolic syndrome had a signifi cantly lower wellness score compared to those without metabolic syndrome (73.8 compared to 84.1, P < 0.0001). The wellness score is on a scale of 0 to 100 and includes components of behavioral health risks, mortality risks, and preventive services usage. Behavioral health risks are weighted the most among the three components in the wellness score and preventive services weighted the least. The behavioral health controlling for age and gender. After counting up all health conditions, the average number of conditions reported by participants was signifi cantly greater (P < 0.0001) for those with metabolic syndrome (1.01 conditions per person) compared to those without metabolic syndrome (0.68 conditions per person).
Workplace outcomes were then considered. The healthcare and pharmaceutical costs of those with and without each of the metabolic syndrome risks were compared, as were the costs of STD absences and the percent of employees reporting any presenteeism. Table 6 contains those results.
When examining the health-care costs, those at risk for triglycerides and blood pressure had signifi cantly higher health-care costs compared to those not at risk for those factors after controlling for age and gender. For four of the risk factors (HDL was the exception), those with the risk had signifi cantly higher pharmacy costs compared to those not at risk for each factor. STD costs were signifi cantly higher among those with four of the fi ve risks (again, HDL was the exception). The annual STD cost is relatively low compared to health-care and pharmacy costs because only a small percentage of employees incur an STD claim in any 1 year, and the cost of that claim is spread over all employees in each category. The percentage of employees reporting any presenteeism was signifi cantly higher for those at risk for triglycerides compared to those not at risk for triglycerides. Table 7 shows those cost outcomes by number of metabolic syndrome risks and also compares those with and without metabolic syndrome. Those who met the criteria for metabolic syndrome (3+ risk factors) had signifi cantly higher health-care ($3340 vs. $1788), pharmacy ($570 vs. $270), and STD ($106 vs. $59) costs compared to those who Abbreviations: HDL, high-density lipoprotein; BMI, body mass index; STD, short-term disability.
(P < 0.05) for increasing numbers of employees reporting presenteeism as the number of risk factors increases. Because researchers are not yet confi dent of the appropriate way to convert presenteeism losses to dollars, [29] [30] [31] that conversion was not made here either.
Discussion
In this manufacturing company population, the prevalence of metabolic syndrome was 30.2%, which is higher than rates reported in nationally representative samples 6 as well as work site studies in fi nancial, 32 aerospace/defense, 10 and chemical 33 sectors, which report metabolic syndrome prevalence of 22.6% to 27%. Differences seen here may be related to geography. This company is headquartered in the midwestern United States, which is known to have higher rates of obesity and diabetes than some other regions of the country. 34 Also, most previous studies of metabolic syndrome used either the WHO or ATP III criteria. The latest defi nition of metabolic syndrome, did not meet the criteria for metabolic syndrome. Also, 36.9% of employees with metabolic syndrome reported any presenteeism compared to 33.4% of those without metabolic syndrome (P < 0.05 after controlling for age and gender). When all monetary costs were added together to create a total cost for each individual (not shown in Table 7 ), those at risk for metabolic syndrome had costs of $4016 compared to $2117 for those not at risk for metabolic syndrome, a difference of $1899 (P < 0.0001 adjusting for age and gender). Figure 1 shows the costs of individuals with zero, one, two, three, four, and fi ve of the metabolic syndrome risk factors. As can be seen in the fi gure, health-care, pharmacy, and total costs are signifi cantly greater for those with three, four, or fi ve risks compared to those with none of the risks. STD costs are signifi cantly higher for those with four or fi ve risks compared to those with none of the risks. Figure 2 presents the percentage of employees reporting any presenteeism by the number of metabolic syndrome risk factors. The Cochran-Armitage test for trend is signifi cant bronchitis/emphysema, chronic pain, depression, diabetes, heart problems, heartburn, and stroke. While the literature provides many examples of the link between heart disease and diabetes with metabolic syndrome, 12-21 a few studies have also shown a relationship between chronic pain and metabolic syndrome. Loevinger, et al. found that women with the chronic pain condition fi bromyalgia were 5.6 times more likely to have metabolic syndrome than healthy controls. 38 Another study indicated that individuals with carpal tunnel syndrome were three times more likely to also have metabolic syndrome. 39 The relationship between metabolic syndrome and carpal tunnel syndrome is not surprising given that increased BMI is a key risk factor in both conditions. 40, 41 Although the HRA does not specify type of arthritis (rheumatoid or osteoarthritis), some researchers have found that metabolic syndrome and rheumatoid arthritis share some of the same characteristics such as insulin resistance and dyslipidemia. 42, 43 The relationship between mental health and metabolic syndrome is not well understood and requires more research. 44, 45 The results shown in Fig. 1 indicate that workplace cost outcomes are signifi cantly higher for those with metabolic syndrome compared to those without metabolic syndrome. Figure 2 also shows that increasing numbers of metabolic syndrome health risks are associated with greater numbers of employees reporting on-the-job productivity losses (presenteeism).
However, as was shown in Table 5 , those with metabolic syndrome are also more likely to have other health conditions compared to those without metabolic syndrome. This is undoubtedly a factor in the higher costs associated with metabolic syndrome. However, since more than half (54.4%) of employed individuals with metabolic syndrome do not yet have a medical condition, they also require interventions to help improve their health risks so they do not reach the level of disease.
Limitations
This study was conducted in an employee population of a single large manufacturing corporation headquartered in the midwestern United States, which may limit the which is used here, identifi es more individuals with metabolic syndrome because of the additional medication component. That is, those with normal glucose, blood pressure, or HDL but who are taking medication for those conditions to keep their values normal will now be counted as high risk for metabolic syndrome. It is surprising that in this population, which enjoys a relatively high income and excellent access to low-cost health care, the prevalence of metabolic syndrome is not substantially lower than that found in nationally representative studies, which include lower-income adults as well as those without health insurance. It appears that the healthy worker effect 35 (HWE) has no impact on the prevalence of metabolic syndrome risks in this population.
A prevalence comparison study in Germany found that while the ATP III criteria identifi ed about 20% of the population as having metabolic syndrome, the defi nition proposed by Grundy et al. 5 and used in the current study identifi ed around 29% of the population as having metabolic syndrome. 36 Furthermore, one study of a National Health and Nutrition Examination Survey (NHANES) stratifi ed sample found a metabolic syndrome prevalence of 34.5% using the ATP III criteria and 39.0% using the IDF criteria, which requires the presence of central obesity. 37 Employees in this study population with metabolic syndrome are signifi cantly more likely to be male and older compared to those without metabolic syndrome. Furthermore, those with metabolic syndrome were more likely to also be at risk for the health risks of high total cholesterol, illness absence days, the use of relaxation medication, perceived physical health, physical inactivity, and high stress. Clearly, individuals with metabolic syndrome also have other health risks they are dealing with. Indeed, the wellness score, which is an overall measure of health risks, is signifi cantly lower for individuals with metabolic syndrome (73.8) compared to those without metabolic syndrome (84.1, P < 0.0001). Organizations that identify individuals with metabolic syndrome would be wise to offer a wide variety of health promotion activities to help improve the diverse health risks of those employees.
Individuals with metabolic syndrome not only have additional health risks, they also have additional health conditions. Out of 14 possible health conditions measured on the HRA, those with metabolic syndrome were signifi cantly more likely to report having arthritis, chronic generalizability of the results. Similar studies should be conducted in a variety of industries to see if the fi ndings are replicated in different demographic and geographic groups. As in most worksite studies, HRA participation is voluntary so the population studied may not always be representative of the entire employee population. However, in this study, a nearly universal participation rate (99%) eliminates that problem. The cross-sectional nature of this study also does not allow for any inference of cause-effect about the associations found.
Another potential limitation of this study is the lack of data available on waist circumference. Although the currently used defi nitions of metabolic syndrome all rely on waist circumference, this measurement has been found to be subject to large amounts of error, particularly in men. One study of metabolic syndrome used both BMI and waist circumference and found the two measures to be highly correlated. 46 Another study compared waist circumference, BMI, and waist-to-hip ratio in their ability to predict abdominal adipose tissue (which is the true aim of the metabolic syndrome obesity risk factor) in men as determined by magnetic resonance imaging. 47 Results showed that waist circumference most uniformly predicts the distribution of adipose tissue in the abdominal region but that the relative strengths of waist circumference and BMI in predicting abdominal adiposity did not differ signifi cantly. The company studied here has added waist circumference to its biometric screening in 2007, so a future study will compare those results with BMI.
Conclusions
Metabolic syndrome is prevalent in working populations in the manufacturing industry. In the case of this predominantly male population of manufacturing employees, 30.2% met the criteria for metabolic syndrome. These employees with metabolic syndrome are signifi cantly more likely to have a variety of other health risks and health conditions compared to those without metabolic syndrome. They also have signifi cantly higher health-care, pharmacy, and STD absence costs and are more likely to report presenteeism. Employers would be wise to address the health risks of employees through health promotion programs and benefi t plan designs that help individuals improve their health and receive appropriate health screenings and medical care.
